Paper · 25715420
Retinal thinning as a marker of disease progression in patients with Wolfram syndrome.
Zmyslowska A and 7 others. Diabetes Care, 2015. Cited by 25 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Retinal thinning as a marker of disease progression in patients with Wolfram syndrome. Papers, record 25715420. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25715420
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Retina | Major topic |
| Wolfram Syndrome | Major topic |
| Adolescent | |
| Adult | |
| Case-Control Studies | |
| Child | |
| Diabetes Mellitus, Type 1 | |
| Diabetic Retinopathy | |
| Disease Progression | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Tomography, Optical Coherence |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,042,926 | Selected Brain Metabolites and Mitochondrial DNA Copy Number as Potential Markers of Ongoing Neurodegeneration in Patients with Wolfram Syndrome. | Metabolites | 2026 | https://conductscience.org/library/papers/42042926 | PubMed |
| 41,998,758 | WFS1 gene delivery rescues visual function in a mouse model of Wolfram syndrome. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/41998758 | PubMed |
| 40,491,524 | A case of a young patient with progressive vision loss: An atypical presentation of the rare Wolfram Syndrome in a Middle Eastern individual. | Am J Ophthalmol Case Rep | 2025 | https://conductscience.org/library/papers/40491524 | PubMed |
| 39,064,493 | Wolfram Syndrome Type I Case Report and Review-Focus on Early Diagnosis and Genetic Variants. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39064493 | PubMed |
| 35,328,914 | Wolfram Syndrome 1: From Genetics to Therapy. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35328914 | PubMed |
| 35,252,627 | Wolfram Syndrome: A case report of two sisters Wolfram Syndrome: Case report of two sisters. | Am J Ophthalmol Case Rep | 2022 | https://conductscience.org/library/papers/35252627 | PubMed |
| 35,136,185 | Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study. | Sci Rep | 2022 | https://conductscience.org/library/papers/35136185 | PubMed |
| 34,831,749 | Urinary Tract Involvement in Wolfram Syndrome: A Narrative Review. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34831749 | PubMed |
| 33,996,696 | Case Report: Ophthalmologic Evaluation Over a Long Follow-Up Time in a Patient With Wolfram Syndrome Type 2: Slowly Progressive Optic Neuropathy as a Possible Clinical Finding. | Front Pediatr | 2021 | https://conductscience.org/library/papers/33996696 | PubMed |
| 33,132,210 | Serum microRNA as indicators of Wolfram syndrome's progression in neuroimaging studies. | BMJ Open Diabetes Res Care | 2020 | https://conductscience.org/library/papers/33132210 | PubMed |
1 to 10 of 17
See all 17 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25715420
GET https://conductscience.org/api/papers/v1/25715420/authors